Please login to the form below

Not currently logged in
Email:
Password:

International life sciences partnership

UK and US life sciences bodies agree to collaborate and promote closer interaction

The Golden Triangle Partnership (GTP), a joint collaboration between the three primary UK life sciences and healthcare networking organisations in Cambridge, London and Oxford, has signed a Memorandum of Understanding (MOU) with BIOCOM, the Southern California life science industry association in the US. BIOCOM is the largest regional life science association in the world, representing more than 550 member companies in that area.

The MOU, announced today at the BIO conference in Chicago, will encourage collaboration between the life science industry in the Golden Triangle and Southern California, promoting international member interaction and business-to-business activity.

"The Golden Triangle Partnership represents 80 per cent of the UK life science industry, providing members with real opportunities to network, partner and collaborate," said Harriet Fear, chief executive of the Eastern Region Biotechnology Initiative (ERBI), which is based in Cambridge and represents 350 members from the pharmaceutical, biotech, medical device and diagnostic fields.

Additionally, GTP and BIOCOM will promote each other's investment and partnering events to their respective members, as well as offering their members reduced rates to each other's signature events. 

"This MOU builds on the GTP's existing collaborations with MassBio and MasMEDIC to extend our network to the US West Coast. The intention is to increase deal flow with companies and investors in Southern California by facilitating introductions and presenting opportunities," commented Tony Jones, Director of the London Biotechnology Network.

"This is an historic initiative linking the Golden Triangle to the hugely active Southern California life sciences community which will provide valuable opportunities for our members," added Jon Rees, chief executive of the Oxfordshire Bioscience Network (OBN).

Joe Panetta, president and CEO of BIOCOM commented: "Southern California and the Golden Triangle are the two most active life science clusters in the world. We are delighted to offer our members opportunities to collaborate and partner with the UK's leading life sciences companies."

ERBI and London Biotechnology Network (LBN) announced last week that they are merging to form a single entity, with offices in Cambridge and London. The new organisation combines a wide range of life science industry sectors, representing commercial, clinical and academic interests, with 60 per cent of the UK's life science industry base, four of the UK's five Academic Health Science Centres and three of the world's top six universities.

The combined group will operate under the ERBI name, until the launch of a new identity at the ERBI annual conference on June 2.

5th May 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Random42 Scientific Communication

Random42 is the world's leading medical animation company. Over the past 25 years we have produced core digital assets for...

Latest intelligence

Is the pharma business model ready for precision medicine?
Precision medicine promises to revolutionise patient outcomes and reduce costs for industry but is pharma ready for it? Blue Latitude Health co-founder Head of Strategy Fred Bassett explores the challenges...
ABPI2018
The NHS and ABPI at 70: inching closer to the triple win
The NHS and UK pharma’s ABPI both turn 70 this year. After years of transactional relationships, there’s a will to work more closely - but friction on prices and value...
What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....

Infographics